ImmunoGen, Inc. (One-Half Interest)
Records under this name other than patents ImmunoGen, Inc. (One-Half Interest) holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 4 of 4 · Back to ImmunoGen, Inc. (One-Half Interest)
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,289,509 | Uses of Immunoconjugates Targeting CD138 Formerly held Lapsed on the fee record Ended Mar 22, 2024 · High confidence | Lapsed on the fee record | Ended Mar 22, 2024 | High confidence |
| US 9,011,864 | Method of Decreasing Cytotoxic Side-Effects and Improving Efficacy of Immunoconjugates Formerly held Lapsed on the fee record Ended Apr 21, 2023 · High confidence | Lapsed on the fee record | Ended Apr 21, 2023 | High confidence |
| US 9,446,146 | Methods and Agents for Improving Targeting of CD138 Expressing Tumor Cells Formerly held Lapsed on the fee record Ended Sep 20, 2020 · High confidence | Lapsed on the fee record | Ended Sep 20, 2020 | High confidence |
| US 9,387,261 | Immunoconjugates Targeting CD138 and Uses Thereof Formerly held Lapsed on the fee record Ended Jul 12, 2020 · High confidence | Lapsed on the fee record | Ended Jul 12, 2020 | High confidence |